PL3756657T3 - Preparaty peptydu n-końcowego aneksyny a1 i sposoby - Google Patents

Preparaty peptydu n-końcowego aneksyny a1 i sposoby

Info

Publication number
PL3756657T3
PL3756657T3 PL20164025.7T PL20164025T PL3756657T3 PL 3756657 T3 PL3756657 T3 PL 3756657T3 PL 20164025 T PL20164025 T PL 20164025T PL 3756657 T3 PL3756657 T3 PL 3756657T3
Authority
PL
Poland
Prior art keywords
annexin
methods
terminal peptide
peptide preparations
preparations
Prior art date
Application number
PL20164025.7T
Other languages
English (en)
Polish (pl)
Inventor
Mir Imran
Original Assignee
Rani Therapeutics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44196421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3756657(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rani Therapeutics, Llc filed Critical Rani Therapeutics, Llc
Publication of PL3756657T3 publication Critical patent/PL3756657T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
    • A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4094—Diagnosing or monitoring seizure diseases, e.g. epilepsy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • A61M2005/14284—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation with needle insertion means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Human Computer Interaction (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL20164025.7T 2009-12-24 2010-12-23 Preparaty peptydu n-końcowego aneksyny a1 i sposoby PL3756657T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28476609P 2009-12-24 2009-12-24
US34033110P 2010-03-15 2010-03-15
US39530410P 2010-05-10 2010-05-10

Publications (1)

Publication Number Publication Date
PL3756657T3 true PL3756657T3 (pl) 2025-07-07

Family

ID=44196421

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20164025.7T PL3756657T3 (pl) 2009-12-24 2010-12-23 Preparaty peptydu n-końcowego aneksyny a1 i sposoby
PL18191328T PL3461478T3 (pl) 2009-12-24 2010-12-23 Połykalne urządzenie dostarczające lek

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18191328T PL3461478T3 (pl) 2009-12-24 2010-12-23 Połykalne urządzenie dostarczające lek

Country Status (11)

Country Link
EP (4) EP2515992B2 (https=)
JP (7) JP2013515576A (https=)
CN (2) CN102905753B (https=)
AU (5) AU2010336330B2 (https=)
CA (1) CA2785168C (https=)
DK (3) DK3461478T3 (https=)
ES (2) ES3031275T3 (https=)
FI (1) FI3756657T3 (https=)
PL (2) PL3756657T3 (https=)
PT (1) PT3756657T (https=)
WO (1) WO2011079302A2 (https=)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2461818B1 (en) 2009-08-03 2018-10-17 Incube Labs, Llc Swallowable capsule and method for stimulating incretin production within the intestinal tract
EP3603624A1 (en) * 2009-12-24 2020-02-05 Rani Therapeutics, LLC Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN102905753B (zh) 2009-12-24 2016-06-29 因卡伯实验室有限责任公司 可吞咽式药剂递送装置和药剂递送方法
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
NO3117865T3 (https=) 2011-01-21 2018-04-07
EP3653223B1 (en) 2011-06-29 2021-08-25 Rani Therapeutics, LLC Device for the oral delivery of therapeutic compounds
PL2726091T3 (pl) * 2011-06-29 2020-08-10 Rani Therapeutics, Llc Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek
EP2968071B1 (en) * 2013-03-15 2021-08-04 Rani Therapeutics, LLC Device for oral delivery of therapeutic compounds
US20150064241A1 (en) * 2013-09-05 2015-03-05 Google Inc. Delivery of Functionalized Particles
CN103479401B (zh) * 2013-09-29 2015-08-19 中山大学附属第一医院 一种肠道生物标志物采样器
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10220076B2 (en) 2014-05-15 2019-03-05 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins
NZ727659A (en) * 2014-06-11 2021-12-24 Massachusetts Inst Technology Residence structures and related methods
WO2016155671A1 (zh) * 2015-04-02 2016-10-06 傅君志 可吞咽式装置
EP3294273A4 (en) * 2015-05-08 2018-12-05 Incube Labs, LLC Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
DK3347050T3 (da) * 2015-09-08 2025-04-14 Rani Therapeutics Llc PCSK9-antistofpræparater til afgivelse i et lumen i mave-tarmkanalen ved hjælp af en indtagelig enhed til afgivelse af lægemiddel
CN109152796A (zh) * 2016-03-09 2019-01-04 因库博实验室有限责任公司 用于将活细胞递送至实体组织的方法和制品
JP2019526423A (ja) 2016-09-09 2019-09-19 ミッチェル・ローレンス・ジョーンズＭｉｔｃｈｅｌｌ Ｌａｗｒｅｎｃｅ ＪＯＮＥＳ 分注可能物質の送達のための電気機械的摂取可能装置
FR3059553B1 (fr) * 2016-12-07 2021-04-23 Univ Grenoble Alpes Dispositif implantable
JP2020513280A (ja) 2016-12-14 2020-05-14 プロジェニティ， インコーポレイテッド 消化管疾病の免疫抑制剤による治療
CN107050578A (zh) * 2017-05-04 2017-08-18 梁曦 一种药物自动注射装置
US11207272B2 (en) * 2017-05-17 2021-12-28 Massachusetts Institute Of Technology Tissue anchoring articles
IL270674B2 (en) * 2017-05-19 2024-12-01 Shalon Tidhar Instruments and methods for collecting samples from the digestive system
CA3067021A1 (en) * 2017-06-12 2018-12-20 Incube Labs, Llc Swallowable capsule, system and method for measuring gastric emptying parameters
CN108324231A (zh) * 2018-03-14 2018-07-27 潍坊学院 一种自清洁上药胶囊内镜
SG11202009767PA (en) * 2018-04-10 2020-10-29 Panacea Biomatx Inc Method and system for making personalized nutritional and pharmaceutical formulations using additive manufacturing
US10675248B2 (en) * 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
JP2021535090A (ja) * 2018-08-15 2021-12-16 リンドラ セラピューティクス， インコーポレイティド 治療薬物の腸内送達のためのシステム
US12128201B2 (en) 2018-08-23 2024-10-29 Baywind Bioventures Capsule device for delivery of active agent to gastrointestinal tract
US12128133B2 (en) * 2018-09-25 2024-10-29 Rani Therapeutics, Llc Ingestible device with expandable enclosure
EP3883635A1 (en) * 2018-11-19 2021-09-29 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
EP3917598B1 (en) 2019-02-01 2025-10-29 Massachusetts Institute of Technology Systems for liquid injection
US12121688B2 (en) 2019-02-01 2024-10-22 Novo Nordisk A/S Medical device with actuation mechanism
AU2020232610A1 (en) * 2019-03-01 2021-09-23 Rani Therapeutics, Llc Propulsive drug delivery from a swallowable device into a patient's intestinal tract
JP7539416B2 (ja) * 2019-06-07 2024-08-23 ノボ・ノルデイスク・エー／エス 送達部材取り外しを有する摂取可能な装置
US11793980B2 (en) * 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device
WO2021071927A1 (en) * 2019-10-08 2021-04-15 Incube Labs, Llc Controlled release formulation delivery device
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
BR112022013732A2 (pt) * 2020-01-14 2022-10-11 Rani Therapeutics Llc Dispositivos deglutíveis para entrega de fármacos em um trato intestinal
BR112022016147A2 (pt) * 2020-02-18 2022-10-25 Rani Therapeutics Llc Injeção de uma formulação terapêutica para dentro de uma parede do trato gastrointestinal
US20240000708A1 (en) * 2020-03-31 2024-01-04 Danmarks Tekniske Universitet A flexible foil for the delivery of therapeutic cargos
EP4171715A4 (en) * 2020-06-29 2024-07-24 The Governing Council of the University of Toronto MAGNETICALLY ACTUATED CAPSULE
CN111772589B (zh) * 2020-08-04 2022-07-12 重庆金山医疗技术研究院有限公司 一种判断胶囊内镜是否适用的检测系统及其探路胶囊
US20230381098A1 (en) * 2020-09-16 2023-11-30 Eli Lilly And Company Oral drug delivery device with expanding arms
US20240358629A1 (en) * 2021-07-19 2024-10-31 Cochlear Limited Self-propelled pharmaceutical delivery capsules
CN113598690B (zh) * 2021-08-10 2023-07-28 安徽光阵光电科技有限公司 一种用于人体体内医疗的内窥镜药丸
KR20240151199A (ko) * 2022-02-21 2024-10-17 라니 테라퓨틱스, 엘엘씨 유체 제제를 위장관 내로 전달하기 위한 디바이스, 조립체, 및 방법
CN119424884B (zh) * 2024-09-29 2025-10-10 北京水木金昇医疗科技服务有限公司 一种递送注射药物的微针胶囊及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474785A (en) * 1990-01-24 1995-12-12 Alza Corporation Delivery system comprising means for controlling internal pressure
US5217449A (en) * 1990-12-11 1993-06-08 Miyarisan Kabushiki Kaisha Medical capsule and apparatus for activating the same
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
AU6517900A (en) 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
JP4643089B2 (ja) * 2001-09-27 2011-03-02 オリンパス株式会社 カプセル型医療装置
JP2002186672A (ja) * 2001-09-28 2002-07-02 Olympus Optical Co Ltd 医療用カプセル装置
FR2835730B1 (fr) * 2002-02-11 2004-12-10 C T M Ct De Transfert Des Micr Dispositif pour la delivrance de substances et le prelevement intracorporel
AU2003243750A1 (en) 2002-06-25 2004-01-06 Sung-Yun Kwon Rapidly dissolving micro-perforator for drug delivery and other applications
US7118531B2 (en) * 2002-09-24 2006-10-10 The Johns Hopkins University Ingestible medical payload carrying capsule with wireless communication
AU2003288516A1 (en) * 2002-12-26 2004-07-22 Given Imaging Ltd. Immobilizable in vivo sensing device
CN1774239A (zh) * 2003-01-29 2006-05-17 埃-皮尔制药公司 用于胃肠道的有效药物递送
US20050058701A1 (en) * 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
JP2005021677A (ja) * 2003-06-10 2005-01-27 Medorekkusu:Kk 経皮投薬用パッドベース、及び注射針
US7857767B2 (en) * 2004-04-19 2010-12-28 Invention Science Fund I, Llc Lumen-traveling device
DE102004026615A1 (de) * 2004-06-01 2005-12-29 Siemens Ag Vorrichtung und Verfahren zur Freisetzung eines in das Körperinnere eines Patienten geführten therapeutischen Mittels
US20060153894A1 (en) * 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
US7430998B2 (en) * 2004-09-13 2008-10-07 Luk Lamellen Und Kupplungsbau Beteiligungs Kg Method for positional determination of an EC motor
WO2006035446A2 (en) * 2004-09-30 2006-04-06 Duocure, Inc. Device and method for treating weight disorders
CN101107038A (zh) * 2005-01-18 2008-01-16 皇家飞利浦电子股份有限公司 电控胶囊
JP5148274B2 (ja) * 2005-05-27 2013-02-20 オリンパス株式会社 被検体内導入装置
US20070078414A1 (en) 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
AU2006334020B2 (en) 2005-12-30 2012-07-05 Mor Research Applications Ltd. Device and method for treating the anal sphincter
GB0603252D0 (en) * 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
US7741273B2 (en) 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
DE102006047537B4 (de) * 2006-10-07 2024-05-16 Sanofi-Aventis Deutschland Gmbh Verfahren und Vorrichtung zur Bestimmung der Position eines Stopfens einer Ampulle für ein Arzneimittel in einem medizinischen Gerät sowie deren Verwendung, ein entsprechendes medizinisches Gerät sowie Herstellung eines medizinischen Geräts
US20080214919A1 (en) * 2006-12-26 2008-09-04 Lifescan, Inc. System and method for implementation of glycemic control protocols
WO2009041525A1 (ja) * 2007-09-26 2009-04-02 Olympus Medical Systems Corp. 被検体内導入システム
CN102905753B (zh) 2009-12-24 2016-06-29 因卡伯实验室有限责任公司 可吞咽式药剂递送装置和药剂递送方法

Also Published As

Publication number Publication date
AU2020203067B2 (en) 2022-08-04
JP2021112609A (ja) 2021-08-05
AU2018203418B2 (en) 2020-02-27
AU2010336330B2 (en) 2016-04-28
JP2018110907A (ja) 2018-07-19
PL3461478T3 (pl) 2020-09-21
AU2022263569A1 (en) 2022-12-08
ES2804716T3 (es) 2021-02-09
JP2023116591A (ja) 2023-08-22
WO2011079302A2 (en) 2011-06-30
AU2016208382B2 (en) 2018-02-15
EP2515992B2 (en) 2024-11-06
JP2013515576A (ja) 2013-05-09
CN105999526A (zh) 2016-10-12
CA2785168A1 (en) 2011-06-30
EP2515992A2 (en) 2012-10-31
EP3461478B1 (en) 2020-04-22
EP4056173B1 (en) 2025-06-25
JP2017014274A (ja) 2017-01-19
AU2022263569B2 (en) 2025-03-06
DK4056173T3 (da) 2025-08-25
AU2020203067A1 (en) 2020-05-28
CN102905753A (zh) 2013-01-30
EP4056173A2 (en) 2022-09-14
AU2018203418A1 (en) 2018-06-07
JP7590811B2 (ja) 2024-11-27
WO2011079302A3 (en) 2011-11-17
JP2015186590A (ja) 2015-10-29
EP3756657A1 (en) 2020-12-30
DK3461478T3 (da) 2020-07-27
CA2785168C (en) 2018-04-17
JP7616937B2 (ja) 2025-01-17
EP2515992A4 (en) 2013-08-28
DK3756657T3 (da) 2025-06-02
FI3756657T3 (fi) 2025-05-30
AU2010336330A1 (en) 2012-07-12
ES3031275T3 (en) 2025-07-07
JP2020058871A (ja) 2020-04-16
CN105999526B (zh) 2019-07-05
CN102905753B (zh) 2016-06-29
PT3756657T (pt) 2025-06-06
EP2515992B1 (en) 2018-10-10
EP4056173A3 (en) 2022-11-23
EP3461478A1 (en) 2019-04-03
EP3756657B1 (en) 2025-03-05
JP6484208B2 (ja) 2019-03-13
AU2016208382A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
PL3756657T3 (pl) Preparaty peptydu n-końcowego aneksyny a1 i sposoby
IL285226A (en) Anti-n3pglu amyloid beta peptide antibodies and uses thereof
IL230918A0 (en) Modified proteins and peptides
LT3725330T (lt) Stabilūs polipeptidų preparatai ir jų naudojimas
HRP20181447T1 (hr) Pripravci glp-1 peptida i njihova priprava
DK2552434T3 (da) Peptider og anvendelse deraf
EP2688579A4 (en) CATIONIC AROMATIC PEPTIDES AND USES THEREOF
DK3591046T3 (da) Amylasepolypeptide
BRPI1014995A2 (pt) ligantes peptídeos para o isolamento e tratamento de células t autoimunes
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
EP2318438A4 (en) ANTI-P2X7 PEPTIDES AND EPITOPES
EP2521564A4 (en) APOE PEPTIDE DIMERS AND USES THEREOF
BRPI1010661A2 (pt) peptídeo
EP2611823A4 (en) PEPTIDES CONTAINING MULTIPLE N-GLYCOSYLATION ACCEPTING ACCEPTANCE SEQUENCES
IL229926A (en) Neil3 peptides and vaccines including the same
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
EP2513137A4 (en) Saposin-a derived peptides and uses thereof
EP2742153A4 (en) PROTEIN AND PEPTIDE LIBRARIES
EP2598636A4 (en) VECTORS AND METHODS FOR EXPRESSION OF RECOMBINANT PROTEINS
IL229956B (en) Mphosphi peptides and vaccines including the same
IL226198B (en) A peptide derived from human lactoferrin for use as an antigen screening agent
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
BR112013009679A2 (pt) peptídeo
EP2450374A4 (en) Peptide and use thereof
GB201121226D0 (en) Modified proteins and peptides